If you would like to learn more about future focusIR related events and roundtables, please submit your details here

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksCaledonia Regulatory News (CLDN)

Share Price Information for Caledonia (CLDN)

Share Price is delayed by 15 minutes
Get Live Data
377.50    2.50 (0.67%)
Bid:
374.50
Ask:
376.50
Spread: 2.00 (0.534%)
Market Cap: £1.93b
CLDN Live PriceLast checked at - London Stock Exchange

Intraday Caledonia Share Chart

Director/PDMR Shareholding

27 Jun 2025 15:00

RNS Number : 8122O
Caledonia Investments PLC
27 June 2025
 

Caledonia Investments plc

 

Notification of transactions of persons discharging managerial responsibilities ("PDMR") or persons closely associated with them ("PCA")

 

Caledonia Investments plc ("Caledonia" or the "Company") has been notified pursuant to the requirements of the UK Market Abuse Regulation of the following transactions in its ordinary shares of 5p ("Shares") involving one of its directors, Jamie Cayzer-Colvin.

 

On 25 June 2025, 16,186 Shares, as noted in the table below, were transferred to Mr Cayzer-Colvin under the Caledonia Investments 2011 Performance Share Scheme ("2011 PSS") and the Caledonia Investments 2020 Deferred Bonus Plan ("DBP") at nil cost. The Shares were sourced from The Caledonia Investments plc Employee Share Trust ("EST"). 

 

Director

2011 PSS

DBP

J M B Cayzer-Colvin

11,520

4,666

 

On the same date, Mr Cayzer-Colvin sold:

 

· 7,630 Shares to the EST to meet the tax liability due; and

· 1,822 Shares to a member of the Cayzer family concert party.

 

Mr Cayzer-Colvin retained 6,734 Shares.

 

Following the above transactions, Mr Cayzer-Colvin's beneficial interests in the Company increased. 

 

Each of these transactions were conducted on-market in London. The Shares were sold to the EST and a member of the Cayzer family concert party at 3712.5p per Share.

 

Mr Cayzer-Colvin's total interests in Shares following the above transactions are as follows: 

 

Description

Number of Shares

Percentage of voting rights

Beneficial

250,969

0.477%

Non-beneficial

203,754

0.387%

Performance share scheme awards

98,559

0.187%

Deferred bonus plan awards

1,488

0.003%

 

Further information required by the UK Market Abuse Regulation in relation to these transactions is set out in the appendix below.

 

 

Enquiries:

Richard Webster

Company Secretary

Tel: +44 20 7802 8080

 

27 June 2025

 

APPENDIX

 

1

 

Details of the person discharging managerial responsibilities / person closely associated

 

a)

 

Name

 

James Michael Beale Cayzer-Colvin

2

 

Reason for the notification

 

a)

 

Position/status

 

Executive Director

b)

 

Initial notification /Amendment

 

Initial notification

3

 

Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor

 

a)

 

Name

 

Caledonia Investments plc

b)

 

LEI

 

2138002FX1MYCA5ZZH32

4

 

Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted

 

a)

 

Description of the financial instrument, type of instrument

 

Identification code

Ordinary 5p shares

 

 

GB0001639920

 

b)

 

Nature of the transaction

 

 

1. Exercise of Caledonia Investments 2011 Performance Share Scheme ("PSS") award

 

2. Exercise of Caledonia Investments 2020 Deferred Bonus Plan ("DBP") award

 

3. Partial sale of shares arising from PSS and DBP exercise to The Caledonia Investments plc Employee Share Trust ("EST")

 

4. Partial sale of shares to a member of the Cazyer family concert party

 

 

c)

 

 

Price(s) and volume(s)

 

1. Exercise of PSS award

 

 

2. Exercise of DBP award

 

 

3. Partial sale of shares arising from PSS award and DBP award to the EST

4. Partial sale of shares to a member of the Cazyer family concert party

 

Price(s)

 

Volume(s)

£nil

 

 

11,520

£nil

 

 

4,666

£37.125

 

 

7,630

£37.125

 

 

1,822

 

d)

 

 

Aggregated information

 

- Aggregated volume

 

- Price

 

 

 

 

N/A (single transaction)

e)

 

Date of the transaction

 

 

25 June 2025

f)

 

Place of the transaction

 

XLON

 

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
DSHBXGDLDGDDGUR
Date   Source Headline
8th Sep 20178:48 amRNSDirectorate Change
6th Sep 20178:53 amRNSNet Asset Value(s)
21st Aug 20179:50 amRNSChange of Registered Office
18th Aug 20179:59 amRNSHolding(s) in Company
4th Aug 20173:46 pmRNSNet Asset Value(s)
24th Jul 20175:09 pmRNSDirector/PDMR Shareholding
20th Jul 20173:28 pmRNSResult of AGM
6th Jul 20173:11 pmRNSReport for quarter ended 30 June 2017
6th Jul 20172:51 pmRNSNet Asset Value(s)
6th Jul 20172:24 pmRNSIncrease in committed bank facilities
6th Jul 20171:11 pmRNSDirector/PDMR Shareholding
5th Jul 20173:22 pmRNSHolding(s) in Company
3rd Jul 20178:45 amRNSBlock listing Interim Review
29th Jun 20173:01 pmRNSDisposal
27th Jun 20177:00 amRNSCapital Markets Day
13th Jun 20179:14 amRNSAnnual Financial Report
12th Jun 20173:17 pmRNSDirector/PDMR Shareholding
8th Jun 20172:31 pmRNSDirector/PDMR Shareholding
7th Jun 20178:45 amRNSNet Asset Value(s)
25th May 20177:00 amRNSFinal Results 31 March 2017
8th May 201710:08 amRNSNet Asset Value(s)
5th May 20171:31 pmRNSHolding(s) in Company
7th Apr 201711:18 amRNSNet Asset Value(s)
31st Mar 20173:20 pmRNSTransaction in Own Shares
13th Mar 201712:36 pmRNSHolding(s) in Company
6th Mar 201712:30 pmRNSNet Asset Value(s)
8th Feb 20173:15 pmRNSDisposal
6th Feb 20171:22 pmRNSNet Asset Value(s)
6th Jan 20172:05 pmRNSInterim Management Statement 31 December 2016
6th Jan 20172:01 pmRNSNet Asset Value(s)
3rd Jan 20179:09 amRNSBlock listing Interim Review
19th Dec 20167:00 amRNSDisposal
13th Dec 20169:25 amRNSHalf-year Report
6th Dec 201612:32 pmRNSNet Asset Value(s)
24th Nov 20167:00 amRNSHalf-year Report
4th Nov 20169:20 amRNSNet Asset Value(s)
7th Oct 201610:42 amRNSNet Asset Value(s)
30th Sep 201611:26 amRNSTransaction in Own Shares
8th Sep 20161:36 pmRNSAcquisition
6th Sep 201611:55 amRNSNet Asset Value(s)
11th Aug 20169:04 amRNSForm 8 (DD) - Avanti Communications Group plc
10th Aug 20169:25 amRNSForm 8.3 - Avanti Communications Group plc
4th Aug 20163:57 pmRNSHolding(s) in Company
4th Aug 20162:31 pmRNSNet Asset Value(s)
22nd Jul 201612:55 pmRNSDirector/PDMR Shareholding
21st Jul 201612:59 pmRNSResult of AGM
12th Jul 20164:31 pmRNSDirector/PDMR Shareholding
12th Jul 20164:29 pmRNSDirector/PDMR Shareholding
12th Jul 201612:18 pmRNSForm 8.3 - Avanti Communications Group plc
11th Jul 20164:54 pmRNSDirector/PDMR Shareholding

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.